nrc health (nasdaq:nrcia and nrcib) has helped healthcare organizations illuminate and improve the moments that matter to patients, residents, physicians, nurses, and staff for 35 years. our empathetic heritage, proprietary methods, and holistic approach enable our partners to better understand the people they care for, and in turn, design experiences that inspire loyalty and trust. for more information call 800-388-4264, write to info@nrchealth.com, or visit www.nrchealth.com.
![National Research logo](/files/LOGO/70487-NRC.png)
Company profile
Ticker
NRC
Exchange
Website
CEO
Michael Hays
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Icon • Syneos Health • Medpace • Incyte • Zymergen • OmniAb ...
SEC CIK
Corporate docs
Subsidiaries
National Research Corporation Canada ...
IRS number
470634000
NRC stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
13 May 24
10-Q
2024 Q1
Quarterly report
9 May 24
8-K
National Research Corporation Announces First Quarter Results
7 May 24
DEF 14A
Definitive proxy
11 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Results of Operations and Financial Condition
13 Feb 24
8-K
National Research Corporation Elevates Leadership Team to Seize Growth Opportunity
17 Jan 24
8-K
Departure of Directors or Certain Officers
2 Jan 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
National Research Corporation Announces Third Quarter 2023 Results
8 Nov 23
Transcripts
NRC
Earnings call transcript
2024 Q1
8 May 24
NRC
Earnings call transcript
2023 Q4
14 Feb 24
NRC
Earnings call transcript
2023 Q3
8 Nov 23
NRC
Earnings call transcript
2023 Q2
2 Aug 23
NRC
Earnings call transcript
2023 Q2
2 Aug 23
NRC
Earnings call transcript
2023 Q1
3 May 23
NRC
Earnings call transcript
2022 Q4
15 Feb 23
NRC
Earnings call transcript
2022 Q3
3 Nov 22
NRC
Earnings call transcript
2022 Q2
6 Aug 22
NRC
Earnings call transcript
2022 Q1
7 May 22
Latest ownership filings
4
Parul Bhandari
10 May 24
4
Penny Ann Wheeler
10 May 24
4
Stephen H Lockhart
10 May 24
4
Donald M Berwick
10 May 24
4
JOHN N NUNNELLY
10 May 24
3
Linda Stacy
3 Apr 24
4
JOHN N NUNNELLY
29 Mar 24
SC 13G/A
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
8 Mar 24
SC 13D/A
Common Property Trust
5 Mar 24
4
Change in insider ownership
5 Mar 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.70 mm | 1.70 mm | 1.70 mm | 1.70 mm | 1.70 mm | 1.70 mm |
Cash burn (monthly) | 1.65 mm | 1.84 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 6.38 mm | 7.10 mm | n/a | n/a | n/a | n/a |
Cash remaining | -4.68 mm | -5.40 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | -2.8 | -2.9 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
57.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 54 |
Opened positions | 42 |
Closed positions | 4 |
Increased positions | 6 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 62.42 bn |
Total shares | 13.80 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Amandla MK Trust | 4.76 mm | $196.22 mm |
Common Property Trust | 3.85 mm | $156.33 mm |
Kayne Anderson Rudnick Investment Management | 3.19 mm | $128.68 mm |
Conestoga Capital Advisors | 784.66 k | $31.08 bn |
QV Investors | 342.25 k | $13.56 mm |
StonePine Asset Management | 170.00 k | $6.73 bn |
BK Bank Of New York Mellon | 116.96 k | $4.63 bn |
SEIC SEI Investments | 61.77 k | $2.45 bn |
USB U.S. Bancorp. | 47.24 k | $1.87 bn |
Williams Jones Wealth Management | 42.00 k | $1.66 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 May 24 | Stephen H Lockhart | Director Stock Option Common Stock | Grant | Acquire A | No | No | 29.76 | 10,906 | 324.56 k | 10,906 |
8 May 24 | Berwick Donald M | Director Stock Option Common Stock | Grant | Acquire A | No | No | 29.76 | 10,906 | 324.56 k | 10,906 |
8 May 24 | Nunnelly John N | Director Stock Option Common Stock | Grant | Acquire A | No | No | 29.76 | 10,906 | 324.56 k | 10,906 |
8 May 24 | Penny Ann Wheeler | Director Stock Option Common Stock | Grant | Acquire A | No | No | 29.76 | 10,906 | 324.56 k | 10,906 |
8 May 24 | Parul Bhandari | Director Stock Option Common Stock | Grant | Acquire A | No | No | 29.76 | 10,906 | 324.56 k | 10,906 |